{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:10:28Z","timestamp":1788977428224,"version":"build-2803163510"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03513-4","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:57:13Z","timestamp":1788976633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Solid Lipid Nanoparticles Based Dry Powder Inhalers for Enhanced Drug Delivery Against Lung Diseases"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2639-8158","authenticated-orcid":false,"given":"Cagla","family":"Onel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6915-0283","authenticated-orcid":false,"given":"Yagmur","family":"Pirincci Tok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9110-3704","authenticated-orcid":false,"given":"Yildiz","family":"Ozsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"3513_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101936","volume":"59","author":"S Momtazmanesh","year":"2023","unstructured":"Momtazmanesh S, Moghaddam SS, Ghamari S-H, Rad EM, Rezaei N, Shobeiri P, et al. Global burden of chronic respiratory diseases and risk factors, 1990\u20132019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023;59:101936. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101936.","journal-title":"EClinicalMedicine"},{"key":"3513_CR2","unstructured":"World Health Organization. World health statistics 2025: monitoring health for the SDGs, Sustainable Development Goals. Geneva; 2025."},{"key":"3513_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.mpdhp.2020.10.001","volume":"26","author":"MA den Bakker","year":"2020","unstructured":"den Bakker MA. Pathology of infectious diseases of the lower respiratory system. Diagn Histopathol. 2020;26:541\u201350. https:\/\/doi.org\/10.1016\/j.mpdhp.2020.10.001.","journal-title":"Diagn Histopathol"},{"key":"3513_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00018-016-2393-9","volume":"74","author":"C Castellani","year":"2017","unstructured":"Castellani C, Assael BM. Cystic fibrosis: a clinical view. Cell Mol Life Sci. 2017;74:129\u201340. https:\/\/doi.org\/10.1007\/s00018-016-2393-9.","journal-title":"Cell Mol Life Sci"},{"key":"3513_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396:1204\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","journal-title":"The Lancet"},{"key":"3513_CR6","unstructured":"World Health Organization. Asthma. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/asthma. Accessed 5 May 2025."},{"key":"3513_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/pharmaceutics15020484","volume":"15","author":"J Lou","year":"2023","unstructured":"Lou J, Duan H, Qin Q, Teng Z, Gan F, Zhou X, et al. Advances in oral drug delivery systems: challenges and opportunities. Pharmaceutics. 2023;15:484. https:\/\/doi.org\/10.3390\/pharmaceutics15020484.","journal-title":"Pharmaceutics"},{"key":"3513_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","volume":"56","author":"NR Labiris","year":"2003","unstructured":"Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56:588\u201399. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01892.x.","journal-title":"Br J Clin Pharmacol"},{"key":"3513_CR9","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1007\/s10853-020-05361-4","volume":"56","author":"DT Pham","year":"2021","unstructured":"Pham DT, Chokamonsirikun A, Phattaravorakarn V, Tiyaboonchai W. Polymeric micelles for pulmonary drug delivery: a comprehensive review. J Mater Sci. 2021;56:2016\u201336. https:\/\/doi.org\/10.1007\/s10853-020-05361-4.","journal-title":"J Mater Sci"},{"key":"3513_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020302","volume":"14","author":"AJ Plaunt","year":"2022","unstructured":"Plaunt AJ, Nguyen TL, Corboz MR, Malinin VS, Cipolla DC. Strategies to overcome biological barriers associated with pulmonary drug delivery. Pharmaceutics. 2022;14:302. https:\/\/doi.org\/10.3390\/pharmaceutics14020302.","journal-title":"Pharmaceutics"},{"key":"3513_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124182","volume":"657","author":"CT Dhege","year":"2024","unstructured":"Dhege CT, Kumar P, Choonara YE. Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS). Int J Pharm. 2024;657:124182. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124182.","journal-title":"Int J Pharm"},{"key":"3513_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107574","volume":"114","author":"I Khan","year":"2025","unstructured":"Khan I, Arshad R, Amaan W, Barkat K, Abdul M, Tabish TA, et al. Novel mucoadhesive lysine based glycated self-nanoemulsifying drug delivery system for targeted delivery against respiratory infection. J Drug Deliv Sci Technol. 2025;114:107574. https:\/\/doi.org\/10.1016\/j.jddst.2025.107574.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3513_CR13","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/pharmaceutics14091974","volume":"14","author":"Y-B Zhang","year":"2022","unstructured":"Zhang Y-B, Xu D, Bai L, Zhou Y-M, Zhang H, Cui Y-L. A review of non-invasive drug delivery through respiratory routes. Pharmaceutics. 2022;14:1974. https:\/\/doi.org\/10.3390\/pharmaceutics14091974.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3513_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/ph19020240","volume":"19","author":"Y Pirincci Tok","year":"2026","unstructured":"Pirincci Tok Y, Demiralp B, G\u00fcng\u00f6r S, Sarikaya AO, Aldeniz EE, Dude UK, et al. Influence of drying methods on redispersibility and dissolution of canagliflozin nanocrystals: a comparative approach. Pharmaceuticals. 2026;19(2):240. https:\/\/doi.org\/10.3390\/ph19020240.","journal-title":"Pharmaceuticals"},{"key":"3513_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan S, Sharma A, Jain V. An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv Pharm Bull. 2023;13:446\u201360. https:\/\/doi.org\/10.34172\/apb.2023.056.","journal-title":"Adv Pharm Bull"},{"key":"3513_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116433","volume":"174","author":"MR Arabestani","year":"2024","unstructured":"Arabestani MR, Bigham A, Kamarehei F, Dini M, Gorjikhah F, Shariati A, et al. Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases. Biomed Pharmacother. 2024;174:116433. https:\/\/doi.org\/10.1016\/j.biopha.2024.116433.","journal-title":"Biomed Pharmacother"},{"key":"3513_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/17425247.2021.1854222","volume":"18","author":"D Chen","year":"2021","unstructured":"Chen D, Liu J, Wu J, Suk JS. Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung. Expert Opin Drug Deliv. 2021;18:595\u2013606. https:\/\/doi.org\/10.1080\/17425247.2021.1854222.","journal-title":"Expert Opin Drug Deliv"},{"key":"3513_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3390\/antiox12030633","volume":"12","author":"E Subroto","year":"2023","unstructured":"Subroto E, Andoyo R, Indiarto R. Solid lipid nanoparticles: review of the current research on encapsulation and delivery systems for active and antioxidant compounds. Antioxidants. 2023;12:633. https:\/\/doi.org\/10.3390\/antiox12030633.","journal-title":"Antioxidants"},{"key":"3513_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1586","author":"CF Anderson","year":"2020","unstructured":"Anderson CF, Grimmett ME, Domalewski CJ, Cui H. Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. WIREs Nanomed Nanobiotechnol. 2020. https:\/\/doi.org\/10.1002\/wnan.1586.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"3513_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124309","volume":"660","author":"PK Paul","year":"2024","unstructured":"Paul PK, Nakpheng T, Paliwal H, Prem Ananth K, Srichana T. Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment. Int J Pharm. 2024;660:124309. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124309.","journal-title":"Int J Pharm"},{"key":"3513_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125926","volume":"682","author":"B Florensia Dana Carla","year":"2025","unstructured":"Florensia Dana Carla B, Fachriza A, Thaufik Umar M, Unawekla JE, Anggraini WA, Mir M, et al. Nanostructured lipid carriers-loaded dry powder inhaler for pulmonary delivery of amphotericin B in treatment of allergic bronchopulmonary aspergillosis. Int J Pharm. 2025;682:125926. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125926.","journal-title":"Int J Pharm"},{"key":"3513_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.seppur.2003.10.002","volume":"38","author":"I Limayem","year":"2004","unstructured":"Limayem I, Charcosset C, Fessi H. Purification of nanoparticle suspensions by a concentration\/diafiltration process. Sep Purif Technol. 2004;38:1\u20139. https:\/\/doi.org\/10.1016\/j.seppur.2003.10.002.","journal-title":"Sep Purif Technol"},{"key":"3513_CR23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/pharmaceutics12090892","volume":"12","author":"TM Amis","year":"2020","unstructured":"Amis TM, Renukuntla J, Bolla PK, Clark BA. Selection of cryoprotectant in lyophilization of progesterone-loaded stearic acid solid lipid nanoparticles. Pharmaceutics. 2020;12:892. https:\/\/doi.org\/10.3390\/pharmaceutics12090892.","journal-title":"Pharmaceutics"},{"key":"3513_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1615\/critrevtherdrugcarriersyst.v26.i6.10","volume":"26","author":"A Puri","year":"2009","unstructured":"Puri A, Loomis K, Smith B, Lee J-H, Yavlovich A, Heldman E, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26:523\u201380. https:\/\/doi.org\/10.1615\/critrevtherdrugcarriersyst.v26.i6.10.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"3513_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1515\/ejnm-2016-0009","volume":"8","author":"AA Attama","year":"2016","unstructured":"Attama AA, Kenechukwu FC, Onuigbo EB, Nnamani PO, Obitte N, Finke JH, et al. Solid lipid nanoparticles encapsulating a fluorescent marker (coumarin 6) and antimalarials \u2013 artemether and lumefantrine: evaluation of cellular uptake and antimalarial activity. Eur J Nanomed. 2016;8:129\u201338. https:\/\/doi.org\/10.1515\/ejnm-2016-0009.","journal-title":"Eur J Nanomed"},{"key":"3513_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165\u201396. https:\/\/doi.org\/10.1016\/S0169-409X(01)00105-3.","journal-title":"Adv Drug Deliv Rev"},{"key":"3513_CR27","doi-asserted-by":"publisher","unstructured":"Ramadon D. Solid lipid nanoparticles (SLN): formulation and fabrication. Pharm Sci Res. 2023;10. https:\/\/doi.org\/10.7454\/psr.v10i2.1313.","DOI":"10.7454\/psr.v10i2.1313"},{"key":"3513_CR28","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s12247-022-09617-1","volume":"17","author":"S Shah","year":"2022","unstructured":"Shah S, Shah N, Amin S, Mori D, Soniwala M, Chavda J. Studies in development and statistical optimization of levofloxacin solid lipid nanoparticles for the treatment of tuberculosis. J Pharm Innov. 2022;17:1322\u201332. https:\/\/doi.org\/10.1007\/s12247-022-09617-1.","journal-title":"J Pharm Innov"},{"key":"3513_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2025.114814","volume":"215","author":"E Fr\u00f6hlich","year":"2025","unstructured":"Fr\u00f6hlich E. Better GRAS than sorry: excipient toxicity in pulmonary formulations. Eur J Pharm Biopharm. 2025;215:114814. https:\/\/doi.org\/10.1016\/j.ejpb.2025.114814.","journal-title":"Eur J Pharm Biopharm"},{"key":"3513_CR30","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/pharmaceutics15051333","volume":"15","author":"KL L\u00f3pez","year":"2023","unstructured":"L\u00f3pez KL, Ravasio A, Gonz\u00e1lez-Aramundiz JV, Zacconi FC. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) prepared by microwave and ultrasound-assisted synthesis: promising green strategies for the nanoworld. Pharmaceutics. 2023;15:1333. https:\/\/doi.org\/10.3390\/pharmaceutics15051333.","journal-title":"Pharmaceutics"},{"key":"3513_CR31","unstructured":"U.S. Food and Drug Administration. Inactive ingredient search for approved drug products. Food and Drug Administration Drug Approvals and Databases. [cited 2026 Mar 10]. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/iig\/index.cfm?event=browseByLetter.page&Letter=G. Accessed 10 Mar 2026."},{"key":"3513_CR32","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/biomedicines10092179","volume":"10","author":"EWX Leong","year":"2022","unstructured":"Leong EWX, Ge R. Lipid nanoparticles as delivery vehicles for inhaled therapeutics. Biomedicines. 2022;10:2179. https:\/\/doi.org\/10.3390\/biomedicines10092179.","journal-title":"Biomedicines"},{"key":"3513_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","volume":"392","author":"G Pilcer","year":"2010","unstructured":"Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm. 2010;392:1\u201319. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.03.017.","journal-title":"Int J Pharm"},{"key":"3513_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1208\/s12249-023-02559-y","volume":"24","author":"HW Chan","year":"2023","unstructured":"Chan HW, Chow S, Zhang X, Zhao Y, Tong HHY, Chow SF. Inhalable nanoparticle-based dry powder formulations for respiratory diseases: challenges and strategies for translational research. AAPS PharmSciTech. 2023;24:98. https:\/\/doi.org\/10.1208\/s12249-023-02559-y.","journal-title":"AAPS PharmSciTech"},{"key":"3513_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2026.104642","volume":"31","author":"B Kaur","year":"2026","unstructured":"Kaur B, S\u00e9cher T, Heuz\u00e9-Vourc\u2019h N. Excipients in orally inhaled protein formulations: current examples, challenges, and future directions. Drug Discov Today. 2026;31:104642. https:\/\/doi.org\/10.1016\/j.drudis.2026.104642.","journal-title":"Drug Discov Today"},{"key":"3513_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1208\/s12249-010-9563-0","volume":"12","author":"S Das","year":"2011","unstructured":"Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 2011;12:62\u201376. https:\/\/doi.org\/10.1208\/s12249-010-9563-0.","journal-title":"AAPS PharmSciTech"},{"key":"3513_CR37","doi-asserted-by":"publisher","unstructured":"Alsaad AAA, Hussien AA, Gareeb MM. Solid lipid nanoparticles (SLN) as a novel drug delivery system: a theoretical review. Systematic Reviews in Pharmacy. EManuscript Technologies; 2020. p. 259\u201373. https:\/\/doi.org\/10.31838\/srp.2020.5.39.","DOI":"10.31838\/srp.2020.5.39"},{"key":"3513_CR38","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","volume":"58","author":"W Abdelwahed","year":"2006","unstructured":"Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations\u2606. Adv Drug Deliv Rev. 2006;58:1688\u2013713. https:\/\/doi.org\/10.1016\/j.addr.2006.09.017.","journal-title":"Adv Drug Deliv Rev"},{"key":"3513_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s42452-024-05897-z","volume":"6","author":"SPN Bukke","year":"2024","unstructured":"Bukke SPN, Venkatesh C, Bandenahalli Rajanna S, Saraswathi TS, Kusuma PK, Goruntla N, et al. Solid lipid nanocarriers for drug delivery: design innovations and characterization strategies\u2014a comprehensive review. Discov Appl Sci. 2024;6:279. https:\/\/doi.org\/10.1007\/s42452-024-05897-z.","journal-title":"Discov Appl Sci"},{"key":"3513_CR40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/jnt5040012","volume":"5","author":"MdeCV Queiroz","year":"2024","unstructured":"Queiroz MdeCV, Muehlmann LA. Characteristics and preparation of solid lipid nanoparticles and nanostructured lipid carriers. J Nanotheranostics. 2024;5:188\u2013211. https:\/\/doi.org\/10.3390\/jnt5040012.","journal-title":"J Nanotheranostics"},{"key":"3513_CR41","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","volume":"54","author":"RH M\u00fcller","year":"2002","unstructured":"M\u00fcller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131\u201355. https:\/\/doi.org\/10.1016\/S0169-409X(02)00118-7.","journal-title":"Adv Drug Deliv Rev"},{"key":"3513_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11746-008-1219-9","volume":"85","author":"T Helgason","year":"2008","unstructured":"Helgason T, Awad TS, Kristbergsson K, McClements DJ, Weiss J. Influence of polymorphic transformations on gelation of tripalmitin solid lipid nanoparticle suspensions. J Am Oil Chem Soc. 2008;85:501\u201311. https:\/\/doi.org\/10.1007\/s11746-008-1219-9.","journal-title":"J Am Oil Chem Soc"},{"key":"3513_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ejpb.2013.08.009","volume":"86","author":"M Schoenitz","year":"2014","unstructured":"Schoenitz M, Joseph S, Nitz A, Bunjes H, Scholl S. Controlled polymorphic transformation of continuously crystallized solid lipid nanoparticles in a microstructured device: a feasibility study. Eur J Pharm Biopharm. 2014;86:324\u201331. https:\/\/doi.org\/10.1016\/j.ejpb.2013.08.009.","journal-title":"Eur J Pharm Biopharm"},{"key":"3513_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/10717544.2017.1413444","volume":"25","author":"S El-Housiny","year":"2018","unstructured":"El-Housiny S, Shams Eldeen MA, El-Attar YA, Salem HA, Attia D, Bendas ER, et al. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. Drug Deliv. 2018;25:78\u201390. https:\/\/doi.org\/10.1080\/10717544.2017.1413444.","journal-title":"Drug Deliv"},{"key":"3513_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/pharmaceutics13040437","volume":"13","author":"P Mura","year":"2021","unstructured":"Mura P, Maestrelli F, D\u2019Ambrosio M, Luceri C, Cirri M. Evaluation and comparison of solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as vectors to develop hydrochlorothiazide effective and safe pediatric oral liquid formulations. Pharmaceutics. 2021;13:437. https:\/\/doi.org\/10.3390\/pharmaceutics13040437.","journal-title":"Pharmaceutics"},{"key":"3513_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/nano9030474","volume":"9","author":"L Bay\u00f3n-Cordero","year":"2019","unstructured":"Bay\u00f3n-Cordero L, Alkorta I, Arana L. Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs. Nanomaterials. 2019;9:474. https:\/\/doi.org\/10.3390\/nano9030474.","journal-title":"Nanomaterials"},{"key":"3513_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/pharmaceutics10040191","volume":"10","author":"V Mishra","year":"2018","unstructured":"Mishra V, Bansal KK, Verma A, Yadav N, Thakur S, Sudhakar K, et al. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics. 2018;10:191. https:\/\/doi.org\/10.3390\/pharmaceutics10040191.","journal-title":"Pharmaceutics"},{"key":"3513_CR48","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jpba.2017.06.072","volume":"147","author":"M Jug","year":"2018","unstructured":"Jug M, Hafner A, Lovri\u0107 J, Kregar ML, Pepi\u0107 I, Vani\u0107 \u017d, et al. An overview of in vitro dissolution\/release methods for novel mucosal drug delivery systems. J Pharm Biomed Anal. 2018;147:350\u201366. https:\/\/doi.org\/10.1016\/j.jpba.2017.06.072.","journal-title":"J Pharm Biomed Anal"},{"key":"3513_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/1735-5362.235156","volume":"13","author":"P Ghasemiyeh","year":"2018","unstructured":"Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 2018;13:288. https:\/\/doi.org\/10.4103\/1735-5362.235156.","journal-title":"Res Pharm Sci"},{"key":"3513_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103768","volume":"76","author":"A Gordillo-Galeano","year":"2022","unstructured":"Gordillo-Galeano A, Ponce A, Mora-Huertas CE. In vitro release behavior of SLN, NLC, and NE: an explanation based on the particle structure and carried molecule location. J Drug Deliv Sci Technol. 2022;76:103768. https:\/\/doi.org\/10.1016\/j.jddst.2022.103768.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3513_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106969","volume":"109","author":"AO Al Khatib","year":"2025","unstructured":"Al Khatib AO, Yousfan A, Abed A, El-Tanani M, Al-Obaidi H. Development of pimozide spray dried lipid nanoparticles with enhanced targeting of non-small cell lung cancer. J Drug Deliv Sci Technol. 2025;109:106969. https:\/\/doi.org\/10.1016\/j.jddst.2025.106969.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3513_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2018.01.001","volume":"125","author":"S Haque","year":"2018","unstructured":"Haque S, Whittaker M, McIntosh MP, Pouton CW, Phipps S, Kaminskas LM. A comparison of the lung clearance kinetics of solid lipid nanoparticles and liposomes by following the 3H-labelled structural lipids after pulmonary delivery in rats. Eur J Pharm Biopharm. 2018;125:1\u201312. https:\/\/doi.org\/10.1016\/j.ejpb.2018.01.001.","journal-title":"Eur J Pharm Biopharm"},{"key":"3513_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061593","volume":"15","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patr\u00edcio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics. 2023;15:1593. https:\/\/doi.org\/10.3390\/pharmaceutics15061593.","journal-title":"Pharmaceutics"},{"key":"3513_CR54","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/1735-5362.235156","volume":"13","author":"P Ghasemiyeh","year":"2018","unstructured":"Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 2018;13:288. https:\/\/doi.org\/10.4103\/1735-5362.235156.","journal-title":"Res Pharm Sci"},{"key":"3513_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00286","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015. https:\/\/doi.org\/10.3389\/fphar.2015.00286.","journal-title":"Front Pharmacol"},{"key":"3513_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126181","volume":"684","author":"S Bonacorsi","year":"2025","unstructured":"Bonacorsi S, Angeloni L, Moliterno M, Saito G, Oddone I, Secci D, et al. Channel-size enlarging strategy for liposome production scale-up: a simplified approach. Int J Pharm. 2025;684:126181. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126181.","journal-title":"Int J Pharm"},{"key":"3513_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8:e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"key":"3513_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/vaccines9040359","volume":"9","author":"TTH Thi","year":"2021","unstructured":"Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park KD, Truong NP. Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines (Basel). 2021;9:359. https:\/\/doi.org\/10.3390\/vaccines9040359.","journal-title":"Vaccines (Basel)"},{"key":"3513_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2025.100209","volume":"8","author":"R Chelliah","year":"2025","unstructured":"Chelliah R, Rubab M, Vijayalakshmi S, Karuvelan M, Barathikannan K, Oh D-H. Liposomes for drug delivery: classification, therapeutic applications, and limitations. Next Nanotechnol. 2025;8:100209. https:\/\/doi.org\/10.1016\/j.nxnano.2025.100209.","journal-title":"Next Nanotechnol"},{"key":"3513_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/chemengineering9030056","volume":"9","author":"S Basak","year":"2025","unstructured":"Basak S, Das TK. Liposome-based drug delivery systems: from laboratory research to industrial production\u2014instruments and challenges. ChemEngineering. 2025;9:56. https:\/\/doi.org\/10.3390\/chemengineering9030056.","journal-title":"ChemEngineering"},{"key":"3513_CR61","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, et al. Polymeric nanoparticles for drug delivery. Chem Rev. 2024;124:5505\u2013616. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00705.","journal-title":"Chem Rev"},{"key":"3513_CR62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1023\/A:1007582911958","volume":"17","author":"K Fu","year":"2000","unstructured":"Fu K, Pack DW, Klibanov AM, Langer R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res. 2000;17:100\u20136. https:\/\/doi.org\/10.1023\/A:1007582911958.","journal-title":"Pharm Res"},{"key":"3513_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/polym16182606","volume":"16","author":"J Yang","year":"2024","unstructured":"Yang J, Zeng H, Luo Y, Chen Y, Wang M, Wu C, et al. Recent applications of PLGA in drug delivery systems. Polymers. 2024;16:2606. https:\/\/doi.org\/10.3390\/polym16182606.","journal-title":"Polymers"},{"key":"3513_CR64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"N Naseri","year":"2015","unstructured":"Naseri N, Valizadeh H, Zakeri-Milani P. Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv Pharm Bull. 2015;5:305\u201313. https:\/\/doi.org\/10.15171\/apb.2015.043.","journal-title":"Adv Pharm Bull"},{"key":"3513_CR65","unstructured":"Fayaz MS, Grace FX. A Sylloge on herbal solid lipid nanoparticles. J Pharm Sci Res. 2023;1063\u20139."},{"key":"3513_CR66","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68807","author":"M Navaneetha Krishnan","year":"2024","unstructured":"Navaneetha Krishnan M, Sangeetha S, Sree Ranjani P, Narayanasamy D. The science of solid lipid nanoparticles: from fundamentals to applications. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.68807.","journal-title":"Cureus"},{"key":"3513_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.scp.2017.07.002","volume":"6","author":"P Ganesan","year":"2017","unstructured":"Ganesan P, Narayanasamy D. Lipid nanoparticles: different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustain Chem Pharm. 2017;6:37\u201356. https:\/\/doi.org\/10.1016\/j.scp.2017.07.002.","journal-title":"Sustain Chem Pharm"},{"key":"3513_CR68","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/pharmaceutics14091886","volume":"14","author":"SV Khairnar","year":"2022","unstructured":"Khairnar SV, Pagare P, Thakre A, Nambiar AR, Junnuthula V, Abraham MC, et al. Review on the scale-up methods for the preparation of solid lipid nanoparticles. Pharmaceutics. 2022;14:1886. https:\/\/doi.org\/10.3390\/pharmaceutics14091886.","journal-title":"Pharmaceutics"},{"key":"3513_CR69","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/17425247.2020.1727883","volume":"17","author":"EB Souto","year":"2020","unstructured":"Souto EB, Baldim I, Oliveira WP, Rao R, Yadav N, Gama FM, et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opin Drug Deliv. 2020;17:357\u201377. https:\/\/doi.org\/10.1080\/17425247.2020.1727883.","journal-title":"Expert Opin Drug Deliv"},{"key":"3513_CR70","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-3-030-50703-9_11","volume-title":"Emerging technologies for nanoparticle manufacturing","author":"P Vinchhi","year":"2021","unstructured":"Vinchhi P, Patel JK, Patel MM. High-pressure homogenization techniques for nanoparticles. In: Emerging technologies for nanoparticle manufacturing. Cham: Springer International Publishing; 2021. p. 263\u201385. https:\/\/doi.org\/10.1007\/978-3-030-50703-9_11."},{"key":"3513_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.111746","volume":"160","author":"F Luisa L\u00fcdtke","year":"2022","unstructured":"Luisa L\u00fcdtke F, Aparecida Stahl M, Grimaldi R, Bruno Soares Forte M, L\u00facia Gigante M, Paula Badan Ribeiro A. Optimization of high pressure homogenization conditions to produce nanostructured lipid carriers using natural and synthetic emulsifiers. Food Res Int. 2022;160:111746. https:\/\/doi.org\/10.1016\/j.foodres.2022.111746.","journal-title":"Food Res Int"},{"key":"3513_CR72","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.foodhyd.2014.09.033","volume":"44","author":"S Alvarez-Sabatel","year":"2015","unstructured":"Alvarez-Sabatel S, de Mara\u00f1\u00f3n IM, Arboleya J-C. Impact of high pressure homogenisation (HPH) on inulin gelling properties, stability and development during storage. Food Hydrocoll. 2015;44:333\u201344. https:\/\/doi.org\/10.1016\/j.foodhyd.2014.09.033.","journal-title":"Food Hydrocoll"},{"key":"3513_CR73","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"J Pardeike","year":"2009","unstructured":"Pardeike J, Hommoss A, M\u00fcller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170\u201384. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.10.003.","journal-title":"Int J Pharm"},{"key":"3513_CR74","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/00914037.2017.1332623","volume":"67","author":"G Amoabediny","year":"2018","unstructured":"Amoabediny G, Haghiralsadat F, Naderinezhad S, Helder MN, Akhoundi Kharanaghi E, Mohammadnejad Arough J, et al. Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: a comprehensive review. Int J Polym Mater Polym Biomater. 2018;67:383\u2013400. https:\/\/doi.org\/10.1080\/00914037.2017.1332623.","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"3513_CR75","doi-asserted-by":"publisher","unstructured":"Esfahani MHM, Ghorbani A, Latifi M. Evaluation of lipid nanocarriers in the form of SLN and their application in drug delivery. Nanochemistry Research. Iranian Chemical Society; 2023;8:57\u201370. https:\/\/doi.org\/10.22036\/ncr.2023.01.006.","DOI":"10.22036\/ncr.2023.01.006"},{"key":"3513_CR76","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.1166\/jnn.2013.7766","volume":"13","author":"C Puglia","year":"2013","unstructured":"Puglia C, Offerta A, Rizza L, Zingale G, Bonina F, Ronsisvalle S. Optimization of curcumin loaded lipid nanoparticles formulated using high shear homogenization (HSH) and ultrasonication (US) methods. J Nanosci Nanotechnol. 2013;13:6888\u201393. https:\/\/doi.org\/10.1166\/jnn.2013.7766.","journal-title":"J Nanosci Nanotechnol"},{"key":"3513_CR77","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11051-008-9402-3","volume":"11","author":"MD Triplett","year":"2009","unstructured":"Triplett MD, Rathman JF. Optimization of \u03b2-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique. J Nanopart Res. 2009;11:601\u201314. https:\/\/doi.org\/10.1007\/s11051-008-9402-3.","journal-title":"J Nanopart Res"},{"key":"3513_CR78","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","volume":"278","author":"EB Souto","year":"2004","unstructured":"Souto EB, Wissing SA, Barbosa CM, M\u00fcller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004;278:71\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2004.02.032.","journal-title":"Int J Pharm"},{"key":"3513_CR79","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/0975-7406.94161","volume":"4","author":"S Upadhyay","year":"2012","unstructured":"Upadhyay S, Patel J, Patel V, Saluja A. Effect of different lipids and surfactants on formulation of solid lipid nanoparticles incorporating tamoxifen citrate. J Pharm Bioallied Sci. 2012;4:112. https:\/\/doi.org\/10.4103\/0975-7406.94161.","journal-title":"J Pharm Bioallied Sci"},{"key":"3513_CR80","first-page":"19670","volume":"8","author":"S-B Sun","year":"2015","unstructured":"Sun S-B, Liu P, Shao F-M, Miao Q-L. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer. Int J Clin Exp Med. 2015;8:19670\u201381.","journal-title":"Int J Clin Exp Med"},{"key":"3513_CR81","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ultsonch.2017.08.018","volume":"40","author":"R Kumar","year":"2018","unstructured":"Kumar R, Singh A, Garg N, Siril PF. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs. Ultrason Sonochem. 2018;40:686\u201396. https:\/\/doi.org\/10.1016\/j.ultsonch.2017.08.018.","journal-title":"Ultrason Sonochem"},{"key":"3513_CR82","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/pr9081265","volume":"9","author":"A Pucek-Kaczmarek","year":"2021","unstructured":"Pucek-Kaczmarek A. Influence of process design on the preparation of solid lipid nanoparticles by an ultrasonic-nanoemulsification method. Processes. 2021;9:1265. https:\/\/doi.org\/10.3390\/pr9081265.","journal-title":"Processes"},{"key":"3513_CR83","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1248\/cpb.49.1444","volume":"49","author":"D-B Chen","year":"2001","unstructured":"Chen D-B, Yang T, Lu W-L, Zhang Q. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem Pharm Bull (Tokyo). 2001;49:1444\u20137. https:\/\/doi.org\/10.1248\/cpb.49.1444.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"3513_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.dib.2015.11.038","volume":"6","author":"D Pooja","year":"2016","unstructured":"Pooja D, Tunki L, Kulhari H, Reddy BB, Sistla R. Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method. Data Brief. 2016;6:15\u20139. https:\/\/doi.org\/10.1016\/j.dib.2015.11.038.","journal-title":"Data Brief"},{"key":"3513_CR85","doi-asserted-by":"publisher","unstructured":"Pannu GK, El-Safy A, Girgis S, Faheem A. Formulation of insulin-loaded nanoparticles by using double emulsion\/solvent evaporation method and microfluidics\/salting out technique. Am J Sustain Cities Soc. 2019;1. https:\/\/doi.org\/10.26808\/rs.aj.i8v1.02.","DOI":"10.26808\/rs.aj.i8v1.02"},{"key":"3513_CR86","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0378-5173(03)00135-2","volume":"257","author":"M Trotta","year":"2003","unstructured":"Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification\u2013diffusion technique. Int J Pharm. 2003;257:153\u201360. https:\/\/doi.org\/10.1016\/S0378-5173(03)00135-2.","journal-title":"Int J Pharm"},{"key":"3513_CR87","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.chemphyslip.2013.05.001","volume":"174","author":"MM Mojahedian","year":"2013","unstructured":"Mojahedian MM, Daneshamouz S, Samani SM, Zargaran A. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o\/w microemulsion quenching technique. Chem Phys Lipids. 2013;174:32\u20138. https:\/\/doi.org\/10.1016\/j.chemphyslip.2013.05.001.","journal-title":"Chem Phys Lipids"},{"key":"3513_CR88","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijpharm.2013.02.027","volume":"446","author":"P Fadda","year":"2013","unstructured":"Fadda P, Monduzzi M, Caboi F, Piras S, Lazzari P. Solid lipid nanoparticle preparation by a warm microemulsion based process: influence of microemulsion microstructure. Int J Pharm. 2013;446:166\u201375. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.02.027.","journal-title":"Int J Pharm"},{"key":"3513_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/03639045.2010.497151","volume":"37","author":"R Yang","year":"2011","unstructured":"Yang R, Gao R, Li F, He H, Tang X. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. Drug Dev Ind Pharm. 2011;37:139\u201348. https:\/\/doi.org\/10.3109\/03639045.2010.497151.","journal-title":"Drug Dev Ind Pharm"},{"key":"3513_CR90","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.colsurfb.2015.12.033","volume":"140","author":"L Becker Peres","year":"2016","unstructured":"Becker Peres L, Becker Peres L, de Ara\u00fajo PHH, Sayer C. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique. Colloids Surf B Biointerfaces. 2016;140:317\u201323. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.12.033.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3513_CR91","doi-asserted-by":"publisher","unstructured":"Joshi S.A RKH. Solid lipid nanoparticle: a review. IOSR J Pharm. 2012;2:34\u201344. https:\/\/doi.org\/10.9790\/3013-26103444.","DOI":"10.9790\/3013-26103444"},{"key":"3513_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/nano12173054","volume":"12","author":"E Subroto","year":"2022","unstructured":"Subroto E, Andoyo R, Indiarto R, Wulandari E, Wadhiah EFN. Preparation of solid lipid nanoparticle-ferrous sulfate by double emulsion method based on fat rich in monolaurin and stearic acid. Nanomaterials (Basel). 2022;12:3054. https:\/\/doi.org\/10.3390\/nano12173054.","journal-title":"Nanomaterials (Basel)"},{"key":"3513_CR93","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/10837450.2019.1703739","volume":"25","author":"A Yassemi","year":"2020","unstructured":"Yassemi A, Kashanian S, Zhaleh H. Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatment. Pharm Dev Technol. 2020;25:397\u2013407. https:\/\/doi.org\/10.1080\/10837450.2019.1703739.","journal-title":"Pharm Dev Technol"},{"key":"3513_CR94","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0378-5173(02)00081-9","volume":"239","author":"FQ Hu","year":"2002","unstructured":"Hu FQ, Yuan H, Zhang HH, Fang M. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm. 2002;239:121\u20138. https:\/\/doi.org\/10.1016\/S0378-5173(02)00081-9.","journal-title":"Int J Pharm"},{"key":"3513_CR95","doi-asserted-by":"publisher","unstructured":"Patravale VB, Mirani AG. Preparation and characterization of solid lipid nanoparticles-based gel for topical delivery. 2019. p. 293\u2013302. https:\/\/doi.org\/10.1007\/978-1-4939-9516-5_20.","DOI":"10.1007\/978-1-4939-9516-5_20"},{"key":"3513_CR96","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/nano7090243","volume":"7","author":"J Kudr","year":"2017","unstructured":"Kudr J, Haddad Y, Richtera L, Heger Z, Cernak M, Adam V, et al. Magnetic nanoparticles: from design and synthesis to real world applications. Nanomaterials. 2017;7:243. https:\/\/doi.org\/10.3390\/nano7090243.","journal-title":"Nanomaterials"},{"key":"3513_CR97","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.3390\/molecules24213881","volume":"24","author":"LN Andrade","year":"2019","unstructured":"Andrade LN, Oliveira DML, Chaud MV, Alves TFR, Nery M, da Silva CF, et al. Praziquantel-solid lipid nanoparticles produced by supercritical carbon dioxide extraction: physicochemical characterization, release profile, and cytotoxicity. Molecules. 2019;24:3881. https:\/\/doi.org\/10.3390\/molecules24213881.","journal-title":"Molecules"},{"key":"3513_CR98","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.supflu.2018.08.001","volume":"143","author":"P Trucillo","year":"2019","unstructured":"Trucillo P, Campardelli R. Production of solid lipid nanoparticles with a supercritical fluid assisted process. J Supercrit Fluids. 2019;143:16\u201323. https:\/\/doi.org\/10.1016\/j.supflu.2018.08.001.","journal-title":"J Supercrit Fluids"},{"key":"3513_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202106580","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang G, Hui Y, Ranaweera S, Zhao C. Microfluidic nanoparticles for drug delivery. Small. 2022. https:\/\/doi.org\/10.1002\/smll.202106580.","journal-title":"Small"},{"key":"3513_CR100","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s13346-023-01398-5","volume":"14","author":"E Weaver","year":"2024","unstructured":"Weaver E, Sommonte F, Hooker A, Denora N, Uddin S, Lamprou DA. Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticles. Drug Deliv Transl Res. 2024;14:266\u201379. https:\/\/doi.org\/10.1007\/s13346-023-01398-5.","journal-title":"Drug Deliv Transl Res"},{"key":"3513_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105837","volume":"97","author":"I Arduino","year":"2024","unstructured":"Arduino I, Santoro A, De Santis S, Iacobazzi RM, Lopedota AA, Paradies E, et al. Microfluidic formulation of diazoxide-loaded solid lipid nanoparticles as a Novel approach for Friedreich\u2019s ataxia treatment. J Drug Deliv Sci Technol. 2024;97:105837. https:\/\/doi.org\/10.1016\/j.jddst.2024.105837.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3513_CR102","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1080\/17425247.2016.1193151","volume":"13","author":"S Ding","year":"2016","unstructured":"Ding S, Anton N, Vandamme TF, Serra CA. Microfluidic nanoprecipitation systems for preparing pure drug or polymeric drug loaded nanoparticles: an overview. Expert Opin Drug Deliv. 2016;13:1447\u201360. https:\/\/doi.org\/10.1080\/17425247.2016.1193151.","journal-title":"Expert Opin Drug Deliv"},{"key":"3513_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100399","volume":"10","author":"MJ Javid-Naderi","year":"2025","unstructured":"Javid-Naderi MJ, Mousavi Shaegh SA. Advanced microfluidic techniques for the preparation of solid lipid nanoparticles: Innovations and biomedical applications. Int J Pharm X. 2025;10:100399. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100399.","journal-title":"Int J Pharm X"},{"key":"3513_CR104","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1007\/s11051-013-1960-3","volume":"15","author":"MB de Jesus","year":"2013","unstructured":"de Jesus MB, Radaic A, Zuhorn IS, de Paula E. Microemulsion extrusion technique: a new method to produce lipid nanoparticles. J Nanopart Res. 2013;15:1960. https:\/\/doi.org\/10.1007\/s11051-013-1960-3.","journal-title":"J Nanopart Res"},{"key":"3513_CR105","doi-asserted-by":"publisher","first-page":"14041","DOI":"10.3390\/ijms241814041","volume":"24","author":"MS Gatto","year":"2023","unstructured":"Gatto MS, Najahi-Missaoui W. Lyophilization of nanoparticles, does it really work? Overview of the current status and challenges. Int J Mol Sci. 2023;24:14041. https:\/\/doi.org\/10.3390\/ijms241814041.","journal-title":"Int J Mol Sci"},{"key":"3513_CR106","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/molecules28041545","volume":"28","author":"D Santonocito","year":"2023","unstructured":"Santonocito D, Sarpietro MG, Castelli F, Lauro MR, Torrisi C, Russo S, et al. Development of solid lipid nanoparticles as dry powder: characterization and formulation considerations. Molecules. 2023;28:1545. https:\/\/doi.org\/10.3390\/molecules28041545.","journal-title":"Molecules"},{"key":"3513_CR107","doi-asserted-by":"publisher","unstructured":"Izutsu K. Applications of freezing and freeze-drying in pharmaceutical formulations. Survival Strategies in Extreme Cold and Desiccation. 2018. p. 371\u201383. https:\/\/doi.org\/10.1007\/978-981-13-1244-1_20.","DOI":"10.1007\/978-981-13-1244-1_20"},{"key":"3513_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-025-00750-w","author":"S-K Lee","year":"2025","unstructured":"Lee S-K, Ha E-S, Park H, Jeong J-S, Shin CY, Kim J-S, et al. Lyophilization of pharmaceuticals: an overview and practical approaches for developing the lyophilization cycle. J Pharm Investig. 2025. https:\/\/doi.org\/10.1007\/s40005-025-00750-w.","journal-title":"J Pharm Investig"},{"key":"3513_CR109","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s10973-014-4275-4","volume":"120","author":"T Andreani","year":"2015","unstructured":"Andreani T, Kiill CP, de Souza ALR, Fangueiro JF, Doktorovov\u00e1 S, Garcia ML, et al. Effect of cryoprotectants on the reconstitution of silica nanoparticles produced by sol\u2013gel technology. J Therm Anal Calorim. 2015;120:1001\u20137. https:\/\/doi.org\/10.1007\/s10973-014-4275-4.","journal-title":"J Therm Anal Calorim"},{"key":"3513_CR110","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/pharmaceutics17010086","volume":"17","author":"ME Bustos Araya","year":"2025","unstructured":"Bustos Araya ME, Ricart AN, Calpena Campmany AC, Prohens R, Mi\u00f1arro CM. Development and characterization of lyophilized chondroitin sulfate-loaded solid lipid nanoparticles: encapsulation efficiency and stability. Pharmaceutics. 2025;17:86. https:\/\/doi.org\/10.3390\/pharmaceutics17010086.","journal-title":"Pharmaceutics"},{"key":"3513_CR111","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4103\/2230-973X.93007","volume":"1","author":"A Bansal","year":"2011","unstructured":"Bansal A, Lale S, Goyal M. Development of lyophilization cycle and effect of excipients on the stability of catalase during lyophilization. Int J Pharm Investig. 2011;1:214. https:\/\/doi.org\/10.4103\/2230-973X.93007.","journal-title":"Int J Pharm Investig"},{"key":"3513_CR112","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-12-820658-4.00011-X","volume-title":"Targeting chronic inflammatory lung diseases using advanced drug delivery systems","author":"N Kumar","year":"2020","unstructured":"Kumar N, Gautam V, Kumar V, Maurya PK. Nanoparticle-based macromolecule drug delivery to lungs. In: Targeting chronic inflammatory lung diseases using advanced drug delivery systems. Elsevier; 2020. p. 227\u201359. https:\/\/doi.org\/10.1016\/B978-0-12-820658-4.00011-X."},{"key":"3513_CR113","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijpharm.2016.11.023","volume":"516","author":"ME Ali","year":"2017","unstructured":"Ali ME, Lamprecht A. Spray freeze drying as an alternative technique for lyophilization of polymeric and lipid-based nanoparticles. Int J Pharm. 2017;516:170\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.11.023.","journal-title":"Int J Pharm"},{"key":"3513_CR114","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1517\/17425247.2012.673278","volume":"9","author":"L Battaglia","year":"2012","unstructured":"Battaglia L, Gallarate M. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv. 2012;9:497\u2013508. https:\/\/doi.org\/10.1517\/17425247.2012.673278.","journal-title":"Expert Opin Drug Deliv"},{"key":"3513_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16050680","volume":"16","author":"MH Abu Elella","year":"2024","unstructured":"Abu Elella MH, Al Khatib AO, Al-Obaidi H. Spray-dried nanolipid powders for pulmonary drug delivery: a comprehensive mini review. Pharmaceutics. 2024;16:680. https:\/\/doi.org\/10.3390\/pharmaceutics16050680.","journal-title":"Pharmaceutics"},{"key":"3513_CR116","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cis.2015.05.003","volume":"223","author":"A Sosnik","year":"2015","unstructured":"Sosnik A, Seremeta KP. Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. Adv Colloid Interface Sci. 2015;223:40\u201354. https:\/\/doi.org\/10.1016\/j.cis.2015.05.003.","journal-title":"Adv Colloid Interface Sci"},{"key":"3513_CR117","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/polym15132973","volume":"15","author":"R Daassi","year":"2023","unstructured":"Daassi R, Durand K, Rodrigue D, Stevanovic T. Optimization of the electrospray process to produce lignin nanoparticles for PLA-based food packaging. Polymers (Basel). 2023;15:2973. https:\/\/doi.org\/10.3390\/polym15132973.","journal-title":"Polymers (Basel)"},{"key":"3513_CR118","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3109\/03639040903241817","volume":"36","author":"M Trotta","year":"2010","unstructured":"Trotta M, Cavalli R, Trotta C, Bussano R, Costa L. Electrospray technique for solid lipid-based particle production. Drug Dev Ind Pharm. 2010;36:431\u20138. https:\/\/doi.org\/10.3109\/03639040903241817.","journal-title":"Drug Dev Ind Pharm"},{"key":"3513_CR119","first-page":"251","volume":"12","author":"E Shanaghi","year":"2020","unstructured":"Shanaghi E, Aghajani M, Esmaeli F, Faramarzi MA, Jahandar H, Amani A. Application of electrospray in preparing solid lipid nanoparticles and optimization of nanoparticles using artificial neural networks. Avicenna J Med Biotechnol. 2020;12:251\u20134.","journal-title":"Avicenna J Med Biotechnol"},{"key":"3513_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpta.2023.100345","volume":"6","author":"Y Liang","year":"2023","unstructured":"Liang Y, Tan RPW, Tan XY, Li SFY. Electrospray drying-mediated coating of cellulose nanocrystal. Carbohydr Polym Technol Appl. 2023;6:100345. https:\/\/doi.org\/10.1016\/j.carpta.2023.100345.","journal-title":"Carbohydr Polym Technol Appl"},{"key":"3513_CR121","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jconrel.2020.10.059","volume":"330","author":"A Tanhaei","year":"2021","unstructured":"Tanhaei A, Mohammadi M, Hamishehkar H, Hamblin MR. Electrospraying as a novel method of particle engineering for drug delivery vehicles. J Control Release. 2021;330:851\u201365. https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.059.","journal-title":"J Control Release"},{"key":"3513_CR122","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cherd.2024.02.016","volume":"203","author":"E Beaupeux","year":"2024","unstructured":"Beaupeux E, Jayaprakash P, Dokmak A, Edorh J-M, Gaiani C, Desobry S, et al. Electrostatic spray drying: advantages for thermosensitive actives. Chem Eng Res Des. 2024;203:688\u201396. https:\/\/doi.org\/10.1016\/j.cherd.2024.02.016.","journal-title":"Chem Eng Res Des"},{"key":"3513_CR123","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1208\/s12249-019-1534-5","volume":"21","author":"V Mohylyuk","year":"2020","unstructured":"Mohylyuk V, Patel K, Scott N, Richardson C, Murnane D, Liu F. Wurster fluidised bed coating of microparticles: towards scalable production of oral sustained-release liquid medicines for patients with swallowing difficulties. AAPS PharmSciTech. 2020;21:3. https:\/\/doi.org\/10.1208\/s12249-019-1534-5.","journal-title":"AAPS PharmSciTech"},{"key":"3513_CR124","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.powtec.2013.07.010","volume":"247","author":"Z Tian","year":"2013","unstructured":"Tian Z, Yi Y, Yuan H, Han J, Zhang X, Xie Y, et al. Solidification of nanostructured lipid carriers (NLCs) onto pellets by fluid-bed coating: preparation, in vitro characterization and bioavailability in dogs. Powder Technol. 2013;247:120\u20137. https:\/\/doi.org\/10.1016\/j.powtec.2013.07.010.","journal-title":"Powder Technol"},{"key":"3513_CR125","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/17425247.2025.2482052","volume":"22","author":"Y Huang","year":"2025","unstructured":"Huang Y, Patil CD, Arte KS, Zhou Q (Tony), Qu L (Lily). Particle surface coating for dry powder inhaler formulations. Expert Opin Drug Deliv. 2025;22:711\u201327. https:\/\/doi.org\/10.1080\/17425247.2025.2482052.","journal-title":"Expert Opin Drug Deliv"},{"key":"3513_CR126","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"3513_CR127","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","volume":"383","author":"N Howlader","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383:640\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1916623.","journal-title":"N Engl J Med"},{"key":"3513_CR128","doi-asserted-by":"publisher","first-page":"411","DOI":"10.7326\/0003-4819-159-6-201309170-00690","volume":"159","author":"LL Humphrey","year":"2013","unstructured":"Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2013;159:411\u201320. https:\/\/doi.org\/10.7326\/0003-4819-159-6-201309170-00690.","journal-title":"Ann Intern Med"},{"key":"3513_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115891","volume":"169","author":"Y Li","year":"2023","unstructured":"Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169:115891. https:\/\/doi.org\/10.1016\/j.biopha.2023.115891.","journal-title":"Biomed Pharmacother"},{"key":"3513_CR130","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1080\/03639045.2017.1310223","volume":"43","author":"Z Bakhtiary","year":"2017","unstructured":"Bakhtiary Z, Barar J, Aghanejad A, Saei AA, Nemati E, Ezzati Nazhad Dolatabadi J, et al. Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer. Drug Dev Ind Pharm. 2017;43:1244\u201353. https:\/\/doi.org\/10.1080\/03639045.2017.1310223.","journal-title":"Drug Dev Ind Pharm"},{"key":"3513_CR131","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1021\/acs.molpharmaceut.7b00846","volume":"15","author":"R Rosi\u00e8re","year":"2018","unstructured":"Rosi\u00e8re R, Van Woensel M, Gelbcke M, Mathieu V, Hecq J, Mathivet T, et al. New folate-grafted chitosan derivative to improve delivery of paclitaxel-loaded solid lipid nanoparticles for lung tumor therapy by inhalation. Mol Pharm. 2018;15:899\u2013910. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00846.","journal-title":"Mol Pharm"},{"key":"3513_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02652048.2021.2002448","volume":"39","author":"P Patel","year":"2022","unstructured":"Patel P, Raval M, Airao V, Bhatt V, Shah P. Silibinin loaded inhalable solid lipid nanoparticles for lung targeting. J Microencapsul. 2022;39:1\u201324. https:\/\/doi.org\/10.1080\/02652048.2021.2002448.","journal-title":"J Microencapsul"},{"key":"3513_CR133","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jcis.2016.07.020","volume":"481","author":"N Soni","year":"2016","unstructured":"Soni N, Soni N, Pandey H, Maheshwari R, Kesharwani P, Tekade RK. Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles. J Colloid Interface Sci. 2016;481:107\u201316. https:\/\/doi.org\/10.1016\/j.jcis.2016.07.020.","journal-title":"J Colloid Interface Sci"},{"key":"3513_CR134","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1038\/s41598-025-18460-6","volume":"16","author":"DM Gaber","year":"2026","unstructured":"Gaber DM, Nafee N, Helmy MW, Abdallah OY. Inhalable herbal nanotherapeutics targeting lung carcinoma. Sci Rep. 2026;16:4530. https:\/\/doi.org\/10.1038\/s41598-025-18460-6.","journal-title":"Sci Rep"},{"key":"3513_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118506","volume":"302","author":"Y-F Chiu","year":"2025","unstructured":"Chiu Y-F, Kao C-C, Chen C-Y, Su C-P, Ma C-H, Kyaw Y, et al. Enhancement of respiratory virus infection by air pollutants. Ecotoxicol Environ Saf. 2025;302:118506. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.118506.","journal-title":"Ecotoxicol Environ Saf"},{"key":"3513_CR136","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3967\/bes2025.036","volume":"38","author":"M Zhang","year":"1990","unstructured":"Zhang M, Zhang R, Zhou Y, Zhou M. Forecast of the burden of lower respiratory infections in the elderly aged 70 and above in China from 1990 to 2050, GBD2021. Biomed Environ Sci. 1990;38:539\u201346. https:\/\/doi.org\/10.3967\/bes2025.036.","journal-title":"Biomed Environ Sci"},{"key":"3513_CR137","unstructured":"World Health Organization. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis [Internet]. 2017. https:\/\/www.who.int\/publications\/i\/item\/WHO-EMP-IAU-2017.12. Accessed 11 May 2025."},{"key":"3513_CR138","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s13346-018-00607-w","volume":"9","author":"E Maretti","year":"2019","unstructured":"Maretti E, Costantino L, Buttini F, Rustichelli C, Leo E, Truzzi E, et al. Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy. Drug Deliv Transl Res. 2019;9:298\u2013310. https:\/\/doi.org\/10.1007\/s13346-018-00607-w.","journal-title":"Drug Deliv Transl Res"},{"key":"3513_CR139","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/nano10030568","volume":"10","author":"E Truzzi","year":"2020","unstructured":"Truzzi E, Nascimento TL, Iannuccelli V, Costantino L, Lima EM, Leo E, et al. In vivo biodistribution of respirable solid lipid nanoparticles surface-decorated with a mannose-based surfactant: a promising tool for pulmonary tuberculosis treatment? Nanomaterials. 2020;10:568. https:\/\/doi.org\/10.3390\/nano10030568.","journal-title":"Nanomaterials"},{"key":"3513_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9571286","volume":"2021","author":"E Zhao","year":"2021","unstructured":"Zhao E, Yi T, Du J, Wang J, Cong S, Liu Y. Experimental study on the resistance of synthetic penicillin solid lipid nanoparticles to clinically resistant Staphylococcus aureus. Comput Math Methods Med. 2021;2021:1\u20137. https:\/\/doi.org\/10.1155\/2021\/9571286.","journal-title":"Comput Math Methods Med"},{"key":"3513_CR141","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1208\/s12249-019-1334-y","volume":"20","author":"E Nemati","year":"2019","unstructured":"Nemati E, Mokhtarzadeh A, Panahi-Azar V, Mohammadi A, Hamishehkar H, Mesgari-Abbasi M, et al. Ethambutol-loaded solid lipid nanoparticles as dry powder inhalable formulation for tuberculosis therapy. AAPS PharmSciTech. 2019;20:120. https:\/\/doi.org\/10.1208\/s12249-019-1334-y.","journal-title":"AAPS PharmSciTech"},{"key":"3513_CR142","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020 Report [Internet]. 2020. https:\/\/www.goldcopd.org\/wp-content\/uploads\/2019\/12\/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed 11 May 2025."},{"key":"3513_CR143","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1164\/rccm.200407-855OC","volume":"171","author":"F Pitta","year":"2005","unstructured":"Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:972\u20137. https:\/\/doi.org\/10.1164\/rccm.200407-855OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"3513_CR144","doi-asserted-by":"publisher","unstructured":"Doroudian M, Armstrong ME, Donnelly SC. Nano-based therapies for acute and chronic lung diseases. Biotechnology Applied to Inflammatory Diseases. 2023. p. 271\u201386. https:\/\/doi.org\/10.1007\/978-981-19-8342-9_12.","DOI":"10.1007\/978-981-19-8342-9_12"},{"key":"3513_CR145","doi-asserted-by":"publisher","unstructured":"Atheriya S, Ravi G, Painginkar T, K. GP, Ligade VS, Ranganath Pai KS, et al. An overview of COPD: advanced therapeutic management and challengec for drug release at the targeted site. Int J Appl Pharm. 2025;28\u201354. https:\/\/doi.org\/10.22159\/ijap.2025v17i3.53675.","DOI":"10.22159\/ijap.2025v17i3.53675"},{"key":"3513_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126053","volume":"683","author":"N Li","year":"2025","unstructured":"Li N, Li X, Tan S, Hao D, Wang Z, Fang S, et al. An inhalable composite particulate system for targeted delivery of therapeutics deep into small airways: in vitro and in vivo evaluation. Int J Pharm. 2025;683:126053. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126053.","journal-title":"Int J Pharm"},{"key":"3513_CR147","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejpb.2022.07.017","volume":"178","author":"S Castellani","year":"2022","unstructured":"Castellani S, Trapani A, Elisiana Carpagnano G, Cotoia A, Laselva O, Pia Foschino Barbaro M, et al. Mucopenetration study of solid lipid nanoparticles containing magneto sensitive iron oxide. Eur J Pharm Biopharm. 2022;178:94\u2013104. https:\/\/doi.org\/10.1016\/j.ejpb.2022.07.017.","journal-title":"Eur J Pharm Biopharm"},{"key":"3513_CR148","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0564","author":"S Naehrig","year":"2017","unstructured":"Naehrig S, Chao C-M, Naehrlich L. Cystic fibrosis. Dtsch Arztebl Int. 2017. https:\/\/doi.org\/10.3238\/arztebl.2017.0564.","journal-title":"Dtsch Arztebl Int"},{"key":"3513_CR149","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8:65\u2013124. https:\/\/doi.org\/10.1016\/S2213-2600(19)30337-6.","journal-title":"Lancet Respir Med"},{"key":"3513_CR150","doi-asserted-by":"publisher","DOI":"10.3928\/19382359-20190327-01","author":"D Goetz","year":"2019","unstructured":"Goetz D, Ren CL. Review of cystic fibrosis. Pediatr Ann. 2019. https:\/\/doi.org\/10.3928\/19382359-20190327-01.","journal-title":"Pediatr Ann"},{"key":"3513_CR151","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","volume":"187","author":"PJ Mogayzel","year":"2013","unstructured":"Mogayzel PJ, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, et al. Cystic fibrosis pulmonary guidelines. Am J Respir Crit Care Med. 2013;187:680\u20139. https:\/\/doi.org\/10.1164\/rccm.201207-1160OE.","journal-title":"Am J Respir Crit Care Med"},{"key":"3513_CR152","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","volume":"182","author":"DB Sanders","year":"2010","unstructured":"Sanders DB, Bittner RCL, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010;182:627\u201332. https:\/\/doi.org\/10.1164\/rccm.200909-1421OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"3513_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105068","volume":"89","author":"MM Anjum","year":"2023","unstructured":"Anjum MM, Patel KK, Bhattacharya S, Arya DK, Pandey P, Mr V, et al. Overcoming barriers in cystic fibrosis therapy through inhalational lipid nanoparticles: challenges and advances. J Drug Deliv Sci Technol. 2023;89:105068. https:\/\/doi.org\/10.1016\/j.jddst.2023.105068.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3513_CR154","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.addr.2013.07.020","volume":"65","author":"F Andrade","year":"2013","unstructured":"Andrade F, Rafael D, Videira M, Ferreira D, Sosnik A, Sarmento B. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Adv Drug Deliv Rev. 2013;65:1816\u201327. https:\/\/doi.org\/10.1016\/j.addr.2013.07.020.","journal-title":"Adv Drug Deliv Rev"},{"key":"3513_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120215","volume":"596","author":"J-L Wang","year":"2021","unstructured":"Wang J-L, Hanafy MS, Xu H, Leal J, Zhai Y, Ghosh D, et al. Aerosolizable siRNA-encapsulated solid lipid nanoparticles prepared by thin-film freeze-drying for potential pulmonary delivery. Int J Pharm. 2021;596:120215. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120215.","journal-title":"Int J Pharm"},{"key":"3513_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/136859","volume":"2013","author":"J Varshosaz","year":"2013","unstructured":"Varshosaz J, Ghaffari S, Mirshojaei SF, Jafarian A, Atyabi F, Kobarfard F, et al. Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery. Biomed Res Int. 2013;2013:1\u20138. https:\/\/doi.org\/10.1155\/2013\/136859.","journal-title":"Biomed Res Int"},{"key":"3513_CR157","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.colsurfb.2016.03.040","volume":"143","author":"GA Islan","year":"2016","unstructured":"Islan GA, Tornello PC, Abraham GA, Duran N, Castro GR. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization. Colloids Surf B Biointerfaces. 2016;143:168\u201376. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.03.040.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3513_CR158","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1163\/016942410X525669","volume":"25","author":"Z Xu","year":"2011","unstructured":"Xu Z, Mansour HM, Hickey AJ. Particle interactions in dry powder inhaler unit processes: a review. J Adhes Sci Technol. 2011;25:451\u201382. https:\/\/doi.org\/10.1163\/016942410X525669.","journal-title":"J Adhes Sci Technol"},{"key":"3513_CR159","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1208\/s12249-015-0317-x","volume":"16","author":"K Berkenfeld","year":"2015","unstructured":"Berkenfeld K, Lamprecht A, McConville JT. Devices for dry powder drug delivery to the lung. AAPS PharmSciTech. 2015;16:479\u201390. https:\/\/doi.org\/10.1208\/s12249-015-0317-x.","journal-title":"AAPS PharmSciTech"},{"key":"3513_CR160","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/jamp.2017.1376","volume":"31","author":"G Pohlmann","year":"2018","unstructured":"Pohlmann G, Hohlfeld JM, Haidl P, Pankalla J, Cloes RM. Assessment of the power required for optimal use of current inhalation devices. J Aerosol Med Pulm Drug Deliv. 2018;31:339\u201346. https:\/\/doi.org\/10.1089\/jamp.2017.1376.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"3513_CR161","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1183\/09059180.05.00009605","volume":"14","author":"SP Newman","year":"2005","unstructured":"Newman SP. Inhaler treatment options in COPD. Eur Respir Rev. 2005;14:102\u20138. https:\/\/doi.org\/10.1183\/09059180.05.00009605.","journal-title":"Eur Respir Rev"},{"key":"3513_CR162","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1089\/jam.2006.19.456","volume":"19","author":"HA Tiddens","year":"2006","unstructured":"Tiddens HA, Geller DE, Challoner P, Speirs RJ, Kesser KC, Overbeek SE, et al. Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older. J Aerosol Med. 2006;19:456\u201365. https:\/\/doi.org\/10.1089\/jam.2006.19.456.","journal-title":"J Aerosol Med"},{"key":"3513_CR163","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.3390\/pharmaceutics14112495","volume":"14","author":"AR Mohan","year":"2022","unstructured":"Mohan AR, Wang Q, Dhapare S, Bielski E, Kaviratna A, Han L, et al. Advancements in the design and development of dry powder inhalers and potential implications for generic development. Pharmaceutics. 2022;14:2495. https:\/\/doi.org\/10.3390\/pharmaceutics14112495.","journal-title":"Pharmaceutics"},{"key":"3513_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103954","volume":"29","author":"S Dhoble","year":"2024","unstructured":"Dhoble S, Kapse A, Ghegade V, Chogale M, Ghodake V, Patravale V, et al. Design, development, and technical considerations for dry powder inhaler devices. Drug Discov Today. 2024;29:103954. https:\/\/doi.org\/10.1016\/j.drudis.2024.103954.","journal-title":"Drug Discov Today"},{"key":"3513_CR165","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1742-1241.2011.02832.x","volume":"66","author":"H Chrystyn","year":"2012","unstructured":"Chrystyn H, Niederlaender C. The Genuair\u00ae inhaler: a novel, multidose dry powder inhaler. Int J Clin Pract. 2012;66:309\u201317. https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02832.x.","journal-title":"Int J Clin Pract"},{"key":"3513_CR166","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/jam.1993.6.99","volume":"6","author":"AR Clark","year":"1993","unstructured":"Clark AR, Hollingworth AM. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers \u2014 implications for in vitro testing. J Aerosol Med. 1993;6:99\u2013110. https:\/\/doi.org\/10.1089\/jam.1993.6.99.","journal-title":"J Aerosol Med"},{"key":"3513_CR167","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1185\/03007995.2010.518916","volume":"26","author":"R Pavkov","year":"2010","unstructured":"Pavkov R, Mueller S, Fiebich K, Singh D, Stowasser F, Pignatelli G, et al. Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol. Curr Med Res Opin. 2010;26:2527\u201333. https:\/\/doi.org\/10.1185\/03007995.2010.518916.","journal-title":"Curr Med Res Opin"},{"key":"3513_CR168","doi-asserted-by":"publisher","first-page":"1801147","DOI":"10.1183\/13993003.01147-2018","volume":"52","author":"JD Blakey","year":"2018","unstructured":"Blakey JD, Bender BG, Dima AL, Weinman J, Safioti G, Costello RW. Digital technologies and adherence in respiratory diseases: the road ahead. Eur Respir J. 2018;52:1801147. https:\/\/doi.org\/10.1183\/13993003.01147-2018.","journal-title":"Eur Respir J"},{"key":"3513_CR169","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1208\/s12249-012-9797-0","volume":"13","author":"H Mohammed","year":"2012","unstructured":"Mohammed H, Roberts DL, Copley M, Hammond M, Nichols SC, Mitchell JP. Effect of sampling volume on dry powder inhaler (DPI)-emitted aerosol aerodynamic particle size distributions (APSDs) measured by the next-generation pharmaceutical impactor (NGI) and the Andersen eight-stage cascade impactor (ACI). AAPS PharmSciTech. 2012;13:875\u201382. https:\/\/doi.org\/10.1208\/s12249-012-9797-0.","journal-title":"AAPS PharmSciTech"},{"key":"3513_CR170","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/pharmaceutics17010096","volume":"17","author":"T Mehta","year":"2025","unstructured":"Mehta T, Najafian S, Patel K, Lacombe J, Chaudhuri B. Optimization of carrier-based dry powder inhaler performance: a review. Pharmaceutics. 2025;17:96. https:\/\/doi.org\/10.3390\/pharmaceutics17010096.","journal-title":"Pharmaceutics"},{"key":"3513_CR171","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.3390\/ijms15045852","volume":"15","author":"M Paranjpe","year":"2014","unstructured":"Paranjpe M, M\u00fcller-Goymann C. Nanoparticle-mediated pulmonary drug delivery: a review. Int J Mol Sci. 2014;15:5852\u201373. https:\/\/doi.org\/10.3390\/ijms15045852.","journal-title":"Int J Mol Sci"},{"key":"3513_CR172","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.arbr.2012.02.006","volume":"48","author":"A Fern\u00e1ndez Tena","year":"2012","unstructured":"Fern\u00e1ndez Tena A, Casan CP. Deposition of inhaled particles in the lungs. Arch Bronconeumol (Engl Ed). 2012;48:240\u20136. https:\/\/doi.org\/10.1016\/j.arbr.2012.02.006.","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"3513_CR173","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/wnan.1157","volume":"4","author":"Z Amoozgar","year":"2012","unstructured":"Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. WIREs Nanomed Nanobiotechnol. 2012;4:219\u201333. https:\/\/doi.org\/10.1002\/wnan.1157.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"3513_CR174","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejps.2017.12.006","volume":"114","author":"A Costa","year":"2018","unstructured":"Costa A, Sarmento B, Seabra V. Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages. Eur J Pharm Sci. 2018;114:103\u201313. https:\/\/doi.org\/10.1016\/j.ejps.2017.12.006.","journal-title":"Eur J Pharm Sci"},{"key":"3513_CR175","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/jamp.2009.0797","volume":"23","author":"M Geiser","year":"2010","unstructured":"Geiser M. Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv. 2010;23:207\u201317. https:\/\/doi.org\/10.1089\/jamp.2009.0797.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"3513_CR176","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/bj20031253","volume":"377","author":"J Rejman","year":"2004","unstructured":"Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 2004;377:159\u201369. https:\/\/doi.org\/10.1042\/bj20031253.","journal-title":"Biochem J"},{"key":"3513_CR177","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.colsurfb.2007.06.017","volume":"60","author":"T Hasegawa","year":"2007","unstructured":"Hasegawa T, Hirota K, Tomoda K, Ito F, Inagawa H, Kochi C, et al. Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent. Colloids Surf B Biointerfaces. 2007;60:221\u20138. https:\/\/doi.org\/10.1016\/j.colsurfb.2007.06.017.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3513_CR178","doi-asserted-by":"publisher","unstructured":"Park JH, Oh N. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine. 2014;51. https:\/\/doi.org\/10.2147\/IJN.S26592.","DOI":"10.2147\/IJN.S26592"},{"key":"3513_CR179","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.addr.2014.02.001","volume":"71","author":"B Forbes","year":"2014","unstructured":"Forbes B, O\u2019Lone R, Allen PP, Cahn A, Clarke C, Collinge M, et al. Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses. Adv Drug Deliv Rev. 2014;71:15\u201333. https:\/\/doi.org\/10.1016\/j.addr.2014.02.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"3513_CR180","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169485","volume":"23","author":"TA Adekiya","year":"2022","unstructured":"Adekiya TA, Kumar P, Kondiah PPD, Ubanako P, Choonara YE. In vivo evaluation of praziquantel-loaded solid lipid nanoparticles against S. mansoni infection in preclinical murine models. Int J Mol Sci. 2022;23:9485. https:\/\/doi.org\/10.3390\/ijms23169485.","journal-title":"Int J Mol Sci"},{"key":"3513_CR181","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/01480545.2011.648327","volume":"36","author":"K Owen","year":"2013","unstructured":"Owen K. Regulatory toxicology considerations for the development of inhaled pharmaceuticals. Drug Chem Toxicol. 2013;36:109\u201318. https:\/\/doi.org\/10.3109\/01480545.2011.648327.","journal-title":"Drug Chem Toxicol"},{"key":"3513_CR182","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/00498254.2011.632827","volume":"42","author":"RM Jones","year":"2012","unstructured":"Jones RM, Neef N. Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity. Xenobiotica. 2012;42:86\u201393. https:\/\/doi.org\/10.3109\/00498254.2011.632827.","journal-title":"Xenobiotica"},{"key":"3513_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1715943","author":"C Wood","year":"2026","unstructured":"Wood C, Khera S, Woo M, Sharma V, Lopatecka J, Coulon F, et al. Lung epithelial and alveolar macrophage-like cell interactions significantly modify innate responses to bacterial endotoxin with the involvement of direct cellular contacts, TNF-\u03b1, ICAM1 and MCP-1. Front Immunol. 2026. https:\/\/doi.org\/10.3389\/fimmu.2025.1715943.","journal-title":"Front Immunol"},{"key":"3513_CR184","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12989-022-00494-7","volume":"19","author":"T Smutn\u00e1","year":"2022","unstructured":"Smutn\u00e1 T, Dumkov\u00e1 J, Kristekov\u00e1 D, La\u0161tovi\u010dkov\u00e1 M, Jedli\u010dkov\u00e1 A, Vrl\u00edkov\u00e1 L, et al. Macrophage-mediated tissue response evoked by subchronic inhalation of lead oxide nanoparticles is associated with the alteration of phospholipases C and cholesterol transporters. Part Fibre Toxicol. 2022;19:52. https:\/\/doi.org\/10.1186\/s12989-022-00494-7.","journal-title":"Part Fibre Toxicol"},{"key":"3513_CR185","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3109\/08958378.2013.810315","volume":"25","author":"M Paranjpe","year":"2013","unstructured":"Paranjpe M, Neuhaus V, Finke JH, Richter C, Gothsch T, Kwade A, et al. In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles. Inhal Toxicol. 2013;25:536\u201343. https:\/\/doi.org\/10.3109\/08958378.2013.810315.","journal-title":"Inhal Toxicol"},{"key":"3513_CR186","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","volume":"86","author":"S Weber","year":"2014","unstructured":"Weber S, Zimmer A, Pardeike J. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art. Eur J Pharm Biopharm. 2014;86:7\u201322. https:\/\/doi.org\/10.1016\/j.ejpb.2013.08.013.","journal-title":"Eur J Pharm Biopharm"},{"key":"3513_CR187","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/ph17081059","volume":"17","author":"E Cojocaru","year":"2024","unstructured":"Cojocaru E, Petris OR, Cojocaru C. Nanoparticle-based drug delivery systems in inhaled therapy: improving respiratory medicine. Pharmaceuticals. 2024;17:1059. https:\/\/doi.org\/10.3390\/ph17081059.","journal-title":"Pharmaceuticals"},{"key":"3513_CR188","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3109\/03639045.2014.956111","volume":"41","author":"J Ezzati Nazhad Dolatabadi","year":"2015","unstructured":"Ezzati Nazhad Dolatabadi J, Hamishehkar H, Valizadeh H. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance. Drug Dev Ind Pharm. 2015;41:1431\u20137. https:\/\/doi.org\/10.3109\/03639045.2014.956111.","journal-title":"Drug Dev Ind Pharm"},{"key":"3513_CR189","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.medengphy.2011.12.025","volume":"34","author":"N Islam","year":"2012","unstructured":"Islam N, Cleary MJ. Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery \u2013 a review for multidisciplinary researchers. Med Eng Phys. 2012;34:409\u201327. https:\/\/doi.org\/10.1016\/j.medengphy.2011.12.025.","journal-title":"Med Eng Phys"},{"key":"3513_CR190","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1945-9","volume":"17","author":"J Feng","year":"2019","unstructured":"Feng J, Markwalter CE, Tian C, Armstrong M, Prud\u2019homme RK. Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale. J Transl Med. 2019;17:200. https:\/\/doi.org\/10.1186\/s12967-019-1945-9.","journal-title":"J Transl Med"},{"key":"3513_CR191","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","volume":"16","author":"LX Yu","year":"2014","unstructured":"Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding pharmaceutical quality by design. AAPS J. 2014;16:771\u201383. https:\/\/doi.org\/10.1208\/s12248-014-9598-3.","journal-title":"AAPS J"},{"key":"3513_CR192","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.addr.2020.06.023","volume":"167","author":"SP Newman","year":"2020","unstructured":"Newman SP, Chan H-K. In vitro-in vivo correlations (IVIVCs) of deposition for drugs given by oral inhalation. Adv Drug Deliv Rev. 2020;167:135\u201347. https:\/\/doi.org\/10.1016\/j.addr.2020.06.023.","journal-title":"Adv Drug Deliv Rev"},{"key":"3513_CR193","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1039\/D0BM00558D","volume":"8","author":"R Foulkes","year":"2020","unstructured":"Foulkes R, Man E, Thind J, Yeung S, Joy A, Hoskins C. The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives. Biomater Sci. 2020;8:4653\u201364. https:\/\/doi.org\/10.1039\/D0BM00558D.","journal-title":"Biomater Sci"},{"key":"3513_CR194","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2147\/DDDT.S146111","volume":"14","author":"O Khan","year":"2020","unstructured":"Khan O, Chaudary N. The use of amikacin liposome inhalation suspension (Arikayce) in the treatment of refractory nontuberculous mycobacterial lung disease in adults. Drug Des Devel Ther. 2020;14:2287\u201394. https:\/\/doi.org\/10.2147\/DDDT.S146111.","journal-title":"Drug Des Devel Ther"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03513-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03513-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03513-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:57:19Z","timestamp":1788976639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03513-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":194,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3513"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03513-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare that are relavant to the content of this article.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"281"}}